医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(1R-反式)-(2-苯基环丙基)氨基甲酸叔丁酯 | tert-butyl ((1R,2S)-2-phenylcyclopropyl)carbamate | 185256-47-7 | C14H19NO2 |
|
(1R,9aR)-1-(羟基甲基)八氢-2H-喹嗪鎓氯化物 | (-)-lupinine hydrochloride | 6113-09-3 | C10H19NO*ClH |
|
(1R,5s,6s)-6-氨基-3-氮杂双环[3.1.0]己烷-3-羧酸叔丁酯 | tert-butyl (1S,5R)-6-amino-3-azabicyclo[3.1.0]hexane-3-carboxylate | 273206-92-1 | C10H18N2O2 |
|
(1R,3r)-9h-吡啶并[3,4-b]吲哚-3-羧酸, 1,2,3,4-四氢-1-(3,4-亚甲基二氧基苯基)甲酯盐酸盐 | cis-tetrahydro-β-carboline hydrochloride | 171752-68-4 | C20H18N2O4*ClH |
|
(1R,3r)-1,2,3,4-四氢-1-(3,4-亚甲基二氧基苯基)-9h-吡啶并[3,4-b]吲哚-3-羧酸甲酯 | (1R,3R)-methyl 1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate | 171596-41-1 | C20H18N2O4 |
|
(1R,3S,4S)-N-叔丁氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸 | (1R,3S,4S)-2-aza-bicyclo[2.2.1]heptane-2,3-dicarboxylic acid 2-tert-butyl ester | 291775-59-2 | C12H19NO4 |
|
(1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 | 3-(6-bromo-1H-benzoimidazol-2-yl)-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester | 1256387-74-2 | C18H22BrN3O2 |
|
(1R,3S)-3-氨基-1-环戊醇 | tert-butyl ((1S,3R)-3-hydroxycyclopentyl)carbamate | 167465-99-8 | C10H19NO3 |
|
(1R,2S,5S)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-羧酸 | (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 911835-76-2 | C8H13NO2 |
|
(1R,2S,5S)-3-(叔丁氧基羰基)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-羧酸 | (1R,2S,5S)-3-(tert-butoxycarbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 219754-02-6 | C13H21NO4 |
|
(1R,2S,5R)-7-氧代-6-(苄氧基)-1,6-二氮杂双环[3.2.1]辛烷-2-甲酰胺 | (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide | 1192651-49-2 | C14H17N3O3 |
|
(1R,2S,3S,4R,5S)-1-(乙酰氧甲基)-5-(4-氯-3-(4-乙氧苄基)苯基)-6,8-二氧杂双环[3.2.1]辛烷-2,3,4-三乙酸三酯 | (1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyl triacetate | 1298086-18-6 | C30H33ClO11 |
|
(1R,2S)-2-氟环丙胺对甲苯磺酸盐 | (1R,2S)-2-fluorocyclopropylammonium p-toluenesulfonate | 143062-84-4 | C3H6FN*C7H8O3S |
|
(1R,2S)-2-氟-环丙胺盐酸盐 | (1R,2S)-2-fluorocyclopropylamine hydrochloride | 141042-21-9 | C3H6FN*ClH |
|
(1R,2S)-2-(苄氧甲基)-3-环戊烯-1-醇 | (1R,2S)-2-((benzyloxy)methyl)cyclopent-3-enol | 188399-48-6 | C13H16O2 |
|
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropylamine (R)-mandelate | 376608-71-8 | C8H8O3*C9H9F2N |
|
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (2R,3R)-2,3-二羟基丁二酸盐 | trans-(1R,2S)-2-(3,4-difluorophenyl)-cyclopropylamine tartrate salt | 220352-39-6 | C4H6O6*C9H9F2N |
|
(1R,2S)-2-(3,4-二氟苯基)环丙胺 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine | 220352-38-5 | C9H9F2N |
|
(1R,2S)-1-氨基-N-(环丙基磺酰基)-2-乙烯基环丙烷甲酰胺对甲苯磺酸盐 | (1R,2S)-1-amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide p-toluenesulfonate salt | 1028252-16-5 | C7H8O3S*C9H14N2O3S |
|
(1R,2R,4S)-2-[(5-己烯-1-基甲基氨基)羰基]-4-[[7-甲氧基-8-甲基-2-[4-异丙基-2-噻唑基]-4-喹啉基]氧基]环戊烷羧酸甲酯 | methyl (1R,2R,4S)-2-[5-hexen-1-yl(methyl)carbamoyl]-4-[[2-(4-isopropyl-1,3-thiazol-2-yl)-7-methoxy-8-methyl-4-quinolinyl]oxy]cyclopentanecarboxylate | 1042695-87-3 | C32H41N3O5S |
|
(1R,2R,3S,5R)-(-)-2,3-蒎烷二醇 | (1R,2R,3S,5R)-2,3-pinane diol | 22422-34-0 | C10H18O2 |
|
(1R,2R)-反式-N-Boc-1,2-环戊烷二胺 | tert-butyl ((1R,2R)-2-aminocyclopentyl)carbamate | 1016971-66-6 | C10H20N2O2 |
|
(1R,2R)-2-(3,4-二氟苯基)环丙烷羧酸乙酯 | ethyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropyl carboxylate | 1006376-61-9 | C12H12F2O2 |
|
(1R,2R)-(-)-2-氨基环己醇 | (1R,2R)-2-aminocyclohexanol | 6982-39-4 | C6H13NO |
|
(1R)-5-溴-2,3-二氢-1-甲基-1H-异吲哚 | (1R)-5-bromo-1-methyl-2,3-dihydro-1H-isoindole | 223595-17-3 | C9H10BrN |
|
(1R)-5-溴-1-甲基-2-三苯甲基-2,3-二氢-1H-异吲哚 | (R)-5-bromo-1-methyl-2-trityl-isoindoline | 194805-14-6 | C28H24BrN |
|
(1R)-1,4-脱水-2-脱氧-1-(1,3-二甲基-2,4-二氧代-1,2,3,4-四氢-5-嘧啶基)-D-赤式-戊糖醇 | 1,3-Dimethyl-2'-deoxypseudouridine | 65358-16-9 | C11H16N2O5 |
|
(1R)-(+)-诺蒎酮 | (1R,5S)-(+)-nopinone | 38651-65-9 | C9H14O |
|
(1R)-(+)-TRANS蒎烷 | [1R-(1α,2α,5α)]-2,6,6-trimethylbicyclo[3.1.1]heptane | 4863-59-6 | C10H18 |
|
(1H-吲哚-3-基)-1-丙胺 | Homotryptamine | 6245-89-2 | C11H14N2 |
|
(1H-吲哚-3-基)(2,2,3,3-四甲基环丙基)甲酮 | (1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 895152-66-6 | C16H19NO |
|
(11bR)-2-(环己基羰基)-1,2,3,6,7,11B-六氢-4H-吡嗪并[2,1-a]异喹啉-4-酮 | (R)-praziquantel | 57452-98-9 | C19H24N2O2 |
|
(10-苯基蒽-9-基)硼酸 | 10-phenylanthracene-9-boronic acid | 334658-75-2 | C20H15BO2 |
|
(1-苄基哌嗪-2-基)甲醇 | (1-benzyl-piperazin-2-yl)-methanol | 476493-27-3 | C12H18N2O |
|
(1-苄基吡咯烷-3-基甲基)氨基甲酸叔丁酯 | (1-benzyl-pyrrolidin-3-ylmethyl)-carbamic acid tert-butyl ester | 155497-10-2 | C17H26N2O2 |
|
(1-苄基-1H-吲哚-3-基)甲醇 | N-benzylindole-3-methanol | 60941-76-6 | C16H15NO |
|
(1-苄基-1,2,3,6-四氢吡啶-4-基)甲醇 | (1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)methanol | 158984-76-0 | C13H17NO |
|
(1-甲基吡啶-1-鎓-3-基)N,N-二甲基氨基甲酸酯 | pyridostigmine | 155-97-5 | C9H13N2O2 |
|
(1-甲基-6-吲哚基)甲醇 | (1-methyl-1H-indol-6-yl)methanol | 199590-00-6 | C10H11NO |
|
(1-甲基-4-哌啶基)[3-[2-(3-氯苯基)乙基]吡啶-2-基]甲酮盐酸盐 | (1-methyl-4-piperidinyl)<3-<2-(3-chlorophenyl)ethyl>-2-pyridinyl>methanone hydrochloride | 119770-60-4 | C20H23ClN2O*ClH |
|
(1-甲基-1H-咪唑-4-基)甲醇 | (1-methylimidazol-4-yl)methanol | 17289-25-7 | C5H8N2O |
|
(1-甲基-1H-吡唑-3-基)乙酸 | 2-(1-methyl-1H-pyrazol-3-yl)acetic acid | 1177318-00-1 | C6H8N2O2 |
|
(1-甲基-1H-[1,2,4]噻唑-3-基)-甲醇 | (1-methyl-1H-[1,2,4]-triazol-3-yl)methanol | 135242-93-2 | C4H7N3O |
|
(1-环辛基)哌嗪 | 1-cyclooctylpiperazine | 21043-43-6 | C12H24N2 |
|
(1-烯丙基-1H-苯并咪唑-2-基)甲醇 | (1-allyl-1H-benzo[d]imidazol-2-yl)methanol | 300706-95-0 | C11H12N2O |
|
(1-氧代吡啶-1-鎓-2-基)甲醇 | 2-(hydroxymethyl)pyridine 1-oxide | 10242-36-1 | C6H7NO2 |
|
(1-二苯甲基氮杂啶-3-基)甲基氨基甲酸叔丁酯 | [[1-(diphenylmethyl)-3-azetidinyl]methyl]-carbamic acid 1,1-dimethylethyl ester | 91189-19-4 | C22H28N2O2 |
|
(1-((苄氧基)羰基)-1,2,3,6-四氢吡啶-4-基)硼酸 | (1-((benzyloxy)carbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid | 1251537-33-3 | C13H16BNO4 |
|
(1-((二甲氨基)甲基)环丙基)甲醇 | (1-((dimethylamino)methyl)cyclopropyl)methanol | 39943-41-4 | C7H15NO |
|
(1,2-二氢-2-氧代-3H-吲哚-3-亚基)二对亚苯基二烟酸酯 | 2-Oxo-3,3-bis-(4-nicotinoyloxy-phenyl)-indolin | 5054-75-1 | C32H21N3O5 |
|